JTCS Sign the Guestbook
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Ralf G. Seipelt
Carl L. Backer
Constantine Mavroudis
Friedrich A. Schoendube
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seipelt, R. G.
Right arrow Articles by Crawford, S. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seipelt, R. G.
Right arrow Articles by Crawford, S. E.
Related Collections
Right arrow Congenital - acyanotic
Right arrow Great vessels
Right arrow Peripheral vascular
Right arrow Valve disease

J Thorac Cardiovasc Surg 2005;129:773-781
© 2005 The American Association for Thoracic Surgery


Cardiopulmonary Support and Physiology

Osteopontin expression and adventitial angiogenesis induced by local vascular endothelial growth factor 165 reduces experimental aortic calcification

Ralf G. Seipelt, MDa,b,*, Carl L. Backer, MDa, Constantine Mavroudis, MDa, Veronica Stellmach, PhDc, Mona Cornwell, HATc, Ingrid M. Seipelt, MDc, Friedrich A. Schoendube, MDb, Susan E. Crawford, MDc

a Department of Surgery, Division of Pediatric Cardiovascular Thoracic Surgery, Children’s Memorial Hospital, Northwestern University Feinberg School of Medicine, Chicago, Ill
b Department of Georg August University, GÖttingen, Germany
c Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, Ill

Received for publication May 14, 2004; revisions received June 21, 2004; accepted for publication June 28, 2004.

* Address for reprints: Ralf G. Seipelt, MD, Department of Thoracic and Cardiovascular Surgery, Georg August University, University Hospital, Robert-Koch Str 40, 37075 GÖttingen, Germany (E-mail: rseipelt{at}med.uni-goettingen.de).

BACKGROUND: Vascular calcification is a common pathologic and precisely regulated process involving bone-associated proteins such as osteopontin. In this study, we investigated mechanisms by which recombinant human vascular endothelial growth factor 165 protects the arterial wall from severe vascular remodeling, including calcification, a newly discovered biologic action of vascular endothelial growth factor.

METHODS: In a rabbit model of thoracic aortic end-to-end anastomosis that simulates cardiovascular intervention, recombinant human vascular endothelial growth factor 165 at a dose of 0.75 µg (n = 19) or albumin (control; n = 19) was delivered intraluminally and on the serosal surface. Animals were killed, and aortic tissue was evaluated by Western blotting, immunohistochemistry, and immunofluorescence at 4, 8, and 24 hours; 1 week; and 1 month after surgery.

RESULTS: All controls revealed extensive aortic medial calcification at 1 month, whereas calcification was significantly reduced or absent with vascular endothelial growth factor treatment. Compared with controls, vascular endothelial growth factor treatment resulted in an earlier infiltration of macrophages in the vessel media (at 8 hours: 5.7 ± 2.3 macrophages per high-power field in control vs 32.1 ± 7.5 in vascular endothelial growth factor-treated aortas; P < .001), whereas controls showed an increase in macrophages starting at 1 week (24.1 ± 6.9 vs 4.3 ± 1.8; P < .001). Osteopontin expression was transiently increased and detected in macrophages and endothelial cells in vascular endothelial growth factor-treated vessels, and adventitial microvascular density was significantly increased by 1 week (9.5 ± 0.43 vs 25.0 ± 1.3; P < .001).

CONCLUSIONS: Our data suggest that exogenous vascular endothelial growth factor is capable of increasing adventitial angiogenesis and shifting macrophage infiltration and osteopontin expression in the media to an earlier time point, thereby promoting prompt repair and diminishing vascular remodeling and calcification after acute vascular injury.





This article has been cited by other articles:


Home page
NEJMHome page
R. L. Nachman and S. Rafii
Platelets, Petechiae, and Preservation of the Vascular Wall
N. Engl. J. Med., September 18, 2008; 359(12): 1261 - 1270.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
J. T. Butcher, S. Tressel, T. Johnson, D. Turner, G. Sorescu, H. Jo, and R. M. Nerem
Transcriptional Profiles of Valvular and Vascular Endothelial Cells Reveal Phenotypic Differences: Influence of Shear Stress
Arterioscler Thromb Vasc Biol, January 1, 2006; 26(1): 69 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. G. Seipelt, C. L. Backer, C. Mavroudis, V. Stellmach, M. Cornwell, I. M. Seipelt, F. A. Schoendube, and S. E. Crawford
Local delivery of osteopontin attenuates vascular remodeling by altering matrix metalloproteinase-2 in a rabbit model of aortic injury
J. Thorac. Cardiovasc. Surg., August 1, 2005; 130(2): 355 - 362.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The American Association for Thoracic Surgery.